Effects of the intestinal microbiota on behavior and brain biochemistry

Probiotic Bacteria and Their Effect on Human Health and Well-Being

Volumn 107, Issue , 2013, Pages 56-63

  Barrett, Eoin ^a,b,c   Dinan, Timothy G ^a   Cryan, John F ^a   Quigley, Eamonn M M ^a   Shanahan, Fergus ^a   O'Toole, Paul W ^a,c   Fitzgerald, Gerald F ^a,c   Stanton, Catherine ^a,b   Ross, R Paul ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897063465     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000345749     Document Type: Chapter

References (30)

1. Marques TM, Wall R, Ross RP, Fitzgerald GF, Ryan CA, Stanton C: Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol 2010; 21: 149-156.
2. Shanahan F: The gut microbiota in 2011: translating the microbiota to medicine. Nat Rev Gastroenterol Hepatol 2012; 9: 72-74.
3. Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology - human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
4. Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A: The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
5. Peterson DA, Frank DN, Pace NR, Gordon JI: Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008; 3: 417-427.
6. Rhee SH, Pothoulakis C, Mayer EA: Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6: 306-314.
7. O'Mahony SM, Hyland NP, Dinan TG, Cryan JF: Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology 2011; 214: 71-88.
8. Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, Verdu EF, Collins SM: The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141: 599-601, 601.e1-e3.
9. Cryan JF, O'Mahony SM: The microbiome-gutbrain axis: from bowel to behavior. Neurogastroenterol Motil 2011; 23: 187-192.
10. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y: Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558: 263-275.
11. Neufeld KM, Kang N, Bienenstock J, Foster JA: Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23: 255-264, e119.
12. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG: Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010; 170: 1179-1188.
13. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF: Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011; 108: 16050-16055.
14. Schousboe A, Waagepetersen HS: GABA: Homeostatic and pharmacological aspects; in Tepper JM, Abercrombie ED, Bolam JP (eds): Gaba and the Basal Ganglia: From Molecules to Systems. Amsterdam, Elsevier Science, 2007, pp 9-19.
15. Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C: γ-Amino butyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012; 113: 411-417.
16. Bienenstock J, Forsythe P, Karimi K, Kunze W: Neuroimmune aspects of food intake. Int Dairy J 2010; 20: 253-258.
17. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT: Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221-1227.
18. Schroeder FA, Lin CL, Crusio WE, Akbarian S: Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 2007; 62: 55-64.
19. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR: Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461: 1282-1286.
20. Cryan JF, O'Leary OF: A glutamate pathway to faster-acting antidepressants? Science 2010; 329: 913-914.
21. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G: Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009; 106: 3698-3703.
22. Piomelli D: The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003; 4: 873-884.
23. Muccioli GG, Naslain D, Backhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD: The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010; 6: 15.
24. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, Ouwehand A, Leyer G, Carcano D, Colombel JF, Ardid D, Desreumaux P: Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13: 35-37.
25. FAO/WHO: Report on Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Cοrdoba, FAO/WHO, 2001.
26. Drossman DA, Camilleri M, Mayer EA, Whitehead WE: AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-2131.
27. Clarke G, Quigley EMM, Cryan JF, Dinan TG: Irritable bowel syndrome: towards biomarker identification. Trends Mol Med 2009; 15: 478-489.
28. Wall R, Marques TM, O'Sullivan O, Ross RP, Shanahan F, Quigley EM, Dinan TG, Kiely B, Fitzgerald GF, Cotter PD, Fuohy F, Stanton C: Contrasting effects of Bifidobacterium breve DPC 6330 and Bifidobacterium breve NCIMB 702258 on fatty acid metabolism and gut microbiota composition. Am J Clin Nutr 2012; 95: 1278-1287.
29. Martins JG, Bentsen H, Puri BK: Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. Mol Psychiatry 2012, E-pub ahead of print.
30. Wall R, Ross RP, Shanahan F, O'Mahony L, O'Mahony C, Coakley M, Hart O, Lawlor P, Quigley EM, Kiely B, Fitzgerald GF, Stanton C: Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. Am J Clin Nutr 2009; 89: 1393-1401.